Eratech
Eratech is a drug development company specialized in the field of inhalation drug delivery via nasal and pulmonary administration, for local and systemic therapies.
Eratech's mission is to provide clients with comprehensive and state-of-the-art research, development and product support services.
The support offered by Eratech can be provided at different levels moving from the simple consulting service to the more sophisticated use of Eratech's proprietary formulation technologies.
Eratech is committed to meet even the most demanding expectations of its clients and provides a unique level of expertise, experience, competitive prices and innovation.
Eratech's dedicated research scientists and its highly qualified and specialized consultants have one goal in common: to help clients improve their product.
Health news
WHO news
WHO hails new Gates Foundation support for decade of vaccines
29 January 2010 -- WHO welcomes the Bill & Melinda Gates Foundatio...
Statement of the World Health Organization on allegations of conflict of interest and 'fake' pandemic
22 January 2010 -- Providing independent advice to Member States is a ...
WHO Executive Board appoints Regional Directors
19 January 2010 -- The World Health Organization (WHO) Executive Board...
Health and Fitness: Asthma Articles from EzineArticles.com
Do You Breathe Correctly?
When we breathe naturally and efficiently we use only the diaphragm to...
Two Kinds of Asthma - What's the Difference?
There are two primary kinds of asthma. The first is the type that is s...
How Come in Some Cases People Are Asthmatic Yet Others Are Not?
In earlier times asthma had been frequently thought to be a self-induc...
MedPage Today COPD
Even Mild COPD Affects the Heart
Chronic lung disease begins to affect cardiac function at even mild le...
Emphysema Drug Is Safe, FDA Finds
Inhaled tiotropium bromide (Spiriva HandiHaler) for COPD does not pose...
Tiotropium Appears to Cut Deaths, Cardiovascular Event Rates
Patients taking tiotropium bromide (Spiriva) for chronic obstructive p...